{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:10:00Z","timestamp":1770070200516,"version":"3.49.0"},"reference-count":49,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2011.0714","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:20:20Z","timestamp":1525252820000},"source":"Crossref","is-referenced-by-count":17,"title":["Acute Liver Failure"],"prefix":"10.3238","author":[{"given":"Ali","family":"Canbay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Hadem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2011,10,21]]},"reference":[{"key":"10.3238\/arztebl.2011.0714_ref1","unstructured":"Trey C, Davidson CS: The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282\u201398."},{"key":"10.3238\/arztebl.2011.0714_ref2","doi-asserted-by":"crossref","unstructured":"Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH: Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401\u201315.","DOI":"10.1002\/hep.22177"},{"key":"10.3238\/arztebl.2011.0714_ref3","doi-asserted-by":"crossref","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439\u201345.","DOI":"10.1016\/0016-5085(89)90081-4"},{"key":"10.3238\/arztebl.2011.0714_ref4","doi-asserted-by":"crossref","unstructured":"Bernal W, Wendon J: Liver transplantation in adults with acute liver failure. J Hepatol 2004; 40: 192\u20137.","DOI":"10.1016\/j.jhep.2003.11.020"},{"key":"10.3238\/arztebl.2011.0714_ref5","doi-asserted-by":"crossref","unstructured":"Wei G, Bergquist A, Broom\u00e9 U, et al.: Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262: 393\u2013401.","DOI":"10.1111\/j.1365-2796.2007.01818.x"},{"key":"10.3238\/arztebl.2011.0714_ref6","doi-asserted-by":"crossref","unstructured":"Escorsell A, Mas A, de la Mata M: Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007; 13: 1389\u201395.","DOI":"10.1002\/lt.21119"},{"key":"10.3238\/arztebl.2011.0714_ref7","doi-asserted-by":"crossref","unstructured":"Hadem J, Stiefel P, Bahr MJ, et al.: Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol 2008; 6: 339\u201345.","DOI":"10.1016\/j.cgh.2007.12.039"},{"key":"10.3238\/arztebl.2011.0714_ref8","doi-asserted-by":"crossref","unstructured":"Canbay A, Jochum C, Bechmann LP, et al.: Acute liver failure in a metropolitan area in Germany: a retrospective study (2002\u20132008). Z Gastroenterol 2009; 47: 807\u201313.","DOI":"10.1055\/s-0028-1109058"},{"key":"10.3238\/arztebl.2011.0714_ref9","doi-asserted-by":"crossref","unstructured":"Schimanski CC, Burg J, M\u00f6hler M, et al.: Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure. J Hepatol 2004; 41: 67\u201374.","DOI":"10.1016\/j.jhep.2004.03.010"},{"key":"10.3238\/arztebl.2011.0714_ref10","doi-asserted-by":"crossref","unstructured":"Schmidt LE, Dalhoff K: Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol 2002; 53: 535\u201341.","DOI":"10.1046\/j.1365-2125.2002.01564.x"},{"key":"10.3238\/arztebl.2011.0714_ref11","doi-asserted-by":"crossref","unstructured":"Kr\u00e4henbuhl S, Brauchli Y, Kummer O, et al.: Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage. Digestion 2007; 75: 232\u20137.","DOI":"10.1159\/000111032"},{"key":"10.3238\/arztebl.2011.0714_ref12","doi-asserted-by":"crossref","unstructured":"Strnad P, Zhou Q, Hanada S, et al.: Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology 2010; 139: 828\u201335.","DOI":"10.1053\/j.gastro.2010.06.007"},{"key":"10.3238\/arztebl.2011.0714_ref13","doi-asserted-by":"crossref","unstructured":"Rantala M, van de Laar MJW: Surveillance and epidemiology of hepatitis B and C in Europe \u2013 a review. Euro Surveill [Internet] 2008 [cited 2011]; 13. available from: www.ncbi.nlm.nih.gov\/pubmed\/18761967","DOI":"10.2807\/ese.13.21.18880-en"},{"key":"10.3238\/arztebl.2011.0714_ref14","doi-asserted-by":"crossref","unstructured":"Cornberg M, Protzer U, Dollinger MM, et al.: Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol 2007; 45: 1281\u2013328.","DOI":"10.1055\/s-2007-963714"},{"key":"10.3238\/arztebl.2011.0714_ref15","doi-asserted-by":"crossref","unstructured":"Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U: Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 2007; 13: 1711\u20134.","DOI":"10.3748\/wjg.v13.i11.1711"},{"key":"10.3238\/arztebl.2011.0714_ref16","doi-asserted-by":"crossref","unstructured":"Bechmann LP, Jochum C, Kocabayoglu P, et al.: Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol [Internet] 2010 [cited 2010]; available from: www.ncbi.nlm.nih.gov\/pubmed\/20630612","DOI":"10.1016\/j.jhep.2010.04.029"},{"key":"10.3238\/arztebl.2011.0714_ref17","doi-asserted-by":"crossref","unstructured":"Tacke F, Luedde T, Trautwein C: Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4\u201312.","DOI":"10.1007\/s12016-008-8091-0"},{"key":"10.3238\/arztebl.2011.0714_ref18","doi-asserted-by":"crossref","unstructured":"Jalan R, Hayes PC: Hepatic encephalopathy and ascites. Lancet 1997; 350: 1309\u201315.","DOI":"10.1016\/S0140-6736(97)07503-X"},{"key":"10.3238\/arztebl.2011.0714_ref19","doi-asserted-by":"crossref","unstructured":"Albrecht J, Zieli\u00f1ska M, Norenberg MD: Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal. Biochem Pharmacol 2010; 80: 1303\u20138.","DOI":"10.1016\/j.bcp.2010.07.024"},{"key":"10.3238\/arztebl.2011.0714_ref20","doi-asserted-by":"crossref","unstructured":"Bernal W, Auzinger G, Sizer E, Wendon J: Intensive care management of acute liver failure. Semin Liver Dis 2008; 28: 188\u2013200.","DOI":"10.1055\/s-2008-1073118"},{"key":"10.3238\/arztebl.2011.0714_ref21","doi-asserted-by":"crossref","unstructured":"Honore PM, Jamez J, Wauthier M, et al.: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581\u20137.","DOI":"10.1097\/00003246-200011000-00001"},{"key":"10.3238\/arztebl.2011.0714_ref22","doi-asserted-by":"crossref","unstructured":"Bernal W, Cross TJS, Auzinger G, et al.: Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 2009; 50: 306\u201313.","DOI":"10.1016\/j.jhep.2008.09.012"},{"key":"10.3238\/arztebl.2011.0714_ref23","doi-asserted-by":"crossref","unstructured":"Kamath PS, Kim WR: The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797\u2013805.","DOI":"10.1002\/hep.21563"},{"key":"10.3238\/arztebl.2011.0714_ref24","doi-asserted-by":"crossref","unstructured":"Ostapowicz G, Fontana RJ, Schi\u00f8dt FV, et al.: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947\u201354.","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"10.3238\/arztebl.2011.0714_ref25","doi-asserted-by":"crossref","unstructured":"Heemann U, Treichel U, Loock J, et al.: Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949\u201358.","DOI":"10.1053\/jhep.2002.36130"},{"key":"10.3238\/arztebl.2011.0714_ref26","doi-asserted-by":"crossref","unstructured":"O\u2019Grady JG, Schalm SW, Williams R: Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273\u20135.","DOI":"10.1016\/0140-6736(93)91818-7"},{"key":"10.3238\/arztebl.2011.0714_ref27","unstructured":"Canbay A, Gerken G: Specific therapy in acute liver failure. Med Klin 2006; 101(Suppl 1): 111\u20134."},{"key":"10.3238\/arztebl.2011.0714_ref28","unstructured":"Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA: The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 1995; 27: 3519\u201320."},{"key":"10.3238\/arztebl.2011.0714_ref29","unstructured":"Leifeld L, Merk P, Schmitz V, et al.: Course and therapy of acute liver failure. Eur J Med Res 2008; 13: 87\u201391."},{"key":"10.3238\/arztebl.2011.0714_ref30","doi-asserted-by":"crossref","unstructured":"Lee WM: Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004; 40: 6\u20139.","DOI":"10.1002\/hep.20293"},{"key":"10.3238\/arztebl.2011.0714_ref31","doi-asserted-by":"crossref","unstructured":"Acu\u00f1a G, Foernzler D, Leong D, et al.: Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity. Pharmacogenomics J 2002; 2: 327\u201334.","DOI":"10.1038\/sj.tpj.6500123"},{"key":"10.3238\/arztebl.2011.0714_ref32","doi-asserted-by":"crossref","unstructured":"Jochum C, Gieseler RK, Gawlista I, et al.: Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 2009; 80: 235\u201340.","DOI":"10.1159\/000236009"},{"key":"10.3238\/arztebl.2011.0714_ref33","doi-asserted-by":"crossref","unstructured":"Tillmann HL, Hadem J, Leifeld L, et al.: Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006; 13: 256\u201363.","DOI":"10.1111\/j.1365-2893.2005.00695.x"},{"key":"10.3238\/arztebl.2011.0714_ref34","doi-asserted-by":"crossref","unstructured":"Teschke R: Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues. Ann Hepatol 2009; 8: 184\u201395.","DOI":"10.1016\/S1665-2681(19)31764-8"},{"key":"10.3238\/arztebl.2011.0714_ref35","unstructured":"Wasmuth J, Fischer H, Sauerbruch T, Dumoulin FL: Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine\/cyclophosphamide\/rituximab for low grade non-Hodgkin\u2019s lymphoma. Eur J Med Res 2008; 13: 483\u20136."},{"key":"10.3238\/arztebl.2011.0714_ref36","doi-asserted-by":"crossref","unstructured":"H\u00e4ussinger D, G\u00f6rg B: Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care. 2010; 13: 87\u201392.","DOI":"10.1097\/MCO.0b013e328333b829"},{"key":"10.3238\/arztebl.2011.0714_ref37","doi-asserted-by":"crossref","unstructured":"Bernuau J, Benhamou JP: Classifying acute liver failure. Lancet 1993; 342: 252\u20133.","DOI":"10.1016\/0140-6736(93)91809-Z"},{"key":"10.3238\/arztebl.2011.0714_ref38","doi-asserted-by":"crossref","unstructured":"Auzinger G, Wendon J: Intensive care management of acute liver failure. Curr Opin Crit Care 2008; 14: 179\u201388.","DOI":"10.1097\/MCC.0b013e3282f6a450"},{"key":"10.3238\/arztebl.2011.0714_ref39","doi-asserted-by":"crossref","unstructured":"Eefsen M, Dethloff T, Frederiksen H, Hauerberg J, Hansen BA, Larsen FS: Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol 2007; 47: 381\u20136.","DOI":"10.1016\/j.jhep.2007.04.015"},{"key":"10.3238\/arztebl.2011.0714_ref40","doi-asserted-by":"crossref","unstructured":"Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP: Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996; 16: 415\u201325.","DOI":"10.1055\/s-2007-1007254"},{"key":"10.3238\/arztebl.2011.0714_ref41","doi-asserted-by":"crossref","unstructured":"Dubbeld J, Hoekstra H, Farid W, et al.: Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744\u201353.","DOI":"10.1002\/bjs.7043"},{"key":"10.3238\/arztebl.2011.0714_ref42","unstructured":"Jay C, Skaro A, Ladner D, et al.: A comprehensive risk assessment of mortality following donation after cardiac death liver transplant \u2013 an analysis of the National Registry. J Hepatol [Internet] 2011 [cited 2011]; available from: www.ncbi.nlm.nih.gov\/pubmed\/21338639"},{"key":"10.3238\/arztebl.2011.0714_ref43","doi-asserted-by":"crossref","unstructured":"Heidenhain C, Pratschke J, Puhl G, et al.: Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int 2010; 23: 14\u201322.","DOI":"10.1111\/j.1432-2277.2009.00947.x"},{"key":"10.3238\/arztebl.2011.0714_ref44","doi-asserted-by":"crossref","unstructured":"Bernuau J, Goudeau A, Poynard T, et al.: Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648\u201351.","DOI":"10.1002\/hep.1840060417"},{"key":"10.3238\/arztebl.2011.0714_ref45","doi-asserted-by":"crossref","unstructured":"Schmidt LE, Larsen FS: Blood lactate as a prognostic marker in acetaminophen-induced acute liver failure. Hepatology 2003; 37: 1199\u20131201.","DOI":"10.1002\/hep.510370530"},{"key":"10.3238\/arztebl.2011.0714_ref46","unstructured":"Canbay A, Chen S, Gieseler RK, et al.: Overweight patients are more susceptible for acute liver failure. Hepatogastroenterology 2005; 52: 1516\u201320."},{"key":"10.3238\/arztebl.2011.0714_ref47","doi-asserted-by":"crossref","unstructured":"Rutherford A, Davern T, Hay JE, et al.: Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol 2006; 4: 1544\u20139.","DOI":"10.1016\/j.cgh.2006.07.014"},{"key":"10.3238\/arztebl.2011.0714_ref48","doi-asserted-by":"crossref","unstructured":"Samuel D, Ichai P: Prognosis indicator in acute liver failure: Is there a place for cell death markers? J Hepatol 2010; 53: 593\u20135.","DOI":"10.1016\/j.jhep.2010.06.002"},{"key":"10.3238\/arztebl.2011.0714_ref49","doi-asserted-by":"crossref","unstructured":"Koch A, Trautwein C: N-acetylcysteine on its way to a broader application in patients with acute liver failure. Hepatology 2010; 51: 338\u201340.","DOI":"10.1002\/hep.23484"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T15:01:29Z","timestamp":1638802889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,21]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2011.0714","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,21]]}}}